answersLogoWhite

0

The patent for Tudorza Pressair, which is used for the treatment of chronic obstructive pulmonary disease (COPD), is set to expire in 2028. However, the specific expiration date may vary depending on any extensions or additional patents that could be granted. For the most accurate and current information, it is advisable to consult the United States Patent and Trademark Office or relevant pharmaceutical patent databases.

User Avatar

AnswerBot

1mo ago

What else can I help you with?